Urapidil and Atenolol: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Atenolol
Urapidil
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking two blood pressure medicines together: atenolol (a beta blocker) and urapidil (an alpha blocker). When someone already on a beta blocker starts an alpha blocker, that very first dose can drop blood pressure more than expected, especially when you stand up. You might feel dizzy or lightheaded.
Here's why: your body normally speeds up your heart to make up for a blood pressure drop, but atenolol blunts that response. The good news is your care team knows how to handle this. They often start the alpha blocker at a low dose, usually at bedtime, and keep an eye on your blood pressure. Just report any dizziness to them.
Effect: Beta blockade with atenolol can exaggerate the first-dose hypotensive response to the alpha-1 blocker urapidil, particularly orthostatic hypotension.
Mechanism: Atenolol suppresses the beta-mediated reflex tachycardia that normally compensates for alpha-1 blockade-induced vasodilation. Pharmacodynamic (additive/synergistic), not a prodrug or CYP issue.
- Direction: increased hypotensive effect
- Onset: rapid (first dose)
- Evidence: probable
- Severity: moderate
Management: Initiate urapidil at a reduced starting dose, preferably at bedtime, and monitor closely for hypotension. Adding a beta blocker to established alpha blocker therapy carries lower risk.
What happens
An exaggerated hypotensive response to the first dose of the alpha blocker
Interaction Deep Dive
For patients already receiving beta blockers, the response to a first dose of an alpha-1 adrenergic blocking agent (a pronounced initial fall in blood pressure, especially when standing up) can be amplified23. Such effects tend to be less pronounced with alpha blockers besides prazosin45, though caution remains warranted with every alpha blocker. It is advisable to begin with the smallest feasible starting dose and to administer that first dose at bedtime whenever possible. Conversely, introducing beta blocking agents to a patient already established on alpha blocker treatment is far less likely to produce a meaningful drop in blood pressure3.
Why it happens (mechanism)
Suppression of beta-mediated compensatory increases in heart rate
How to manage this interaction
This combination is manageable with a few sensible precautions your care team will handle.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Your team will typically start the alpha blocker (urapidil) at a lower-than-usual dose, often at bedtime, to reduce the chance of a sharp first-dose blood pressure drop.
- They may monitor your blood pressure more closely early on. Your dose can be adjusted and individualized as needed.
- Rise slowly from sitting or lying down, and report dizziness, lightheadedness, or fainting to your pharmacist or doctor.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) When a single 100 mg dose of atenolol was given together with a single 2.5 mg dose of immediate-release alfuzosin to 8 healthy young male subjects, the Cmax and AUC of alfuzosin rose by 28% and 21%, respectively. Alfuzosin raised the Cmax and AUC of atenolol by 26% and 14%, respectively. In this study, combining alfuzosin with atenolol produced significant decreases in mean blood pressure and mean heart rate 1.
Common questions
Can I take Urapidil and Atenolol together?
Starting urapidil while on atenolol can cause an exaggerated blood pressure drop with the first dose, so it is usually started low and at bedtime with close monitoring. Rise slowly and report any dizziness to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Urapidil and Atenolol interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How is the Urapidil and Atenolol interaction managed?
This combination is manageable with a few sensible precautions your care team will handle. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your team will typically start the alpha blocker (urapidil) at a lower-than-usual dose, often at bedtime, to reduce the chance of a sharp first-dose blood pressure drop. They may monitor your blood pressure more closely early… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Urapidil or Atenolol need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (5)
- Product Information: UROXATRAL(R) oral extended-release tablets, alfuzosin HCl oral extended-release tablets. Sanofi-Aventis US LLC, Bridgewater, NJ, 2008. DailyMed
- Elliott HL, McLean K, Sumner DJ, et al: Immediate cardiovascular responses to oral prazosin: effects of concurrent beta-blockers. Clin Pharmacol Ther 1981; 29:303-309.
- Seideman P, Grahnen A, Haglund K, et al: Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. Br J Clin Pharmacol 1982; 13:865-870. PubMed
- Wilde M, Fitton A, & McTavish D: Alfuzosin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 1993; 45:410-429.
- Miller K: Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents. Drugs 1994; 48:868-887. PubMed
Keep reading about Atenolol
Keep reading about Urapidil
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist